404 related articles for article (PubMed ID: 1317258)
1. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
4. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
5. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
Reeve AE; Sih SA; Raizis AM; Feinberg AP
Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
[TBL] [Abstract][Full Text] [Related]
6. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
7. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
11. Preferential loss of maternal alleles in sporadic Wilms' tumour.
Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
[TBL] [Abstract][Full Text] [Related]
12. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
13. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
[TBL] [Abstract][Full Text] [Related]
14. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
[TBL] [Abstract][Full Text] [Related]
17. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
[TBL] [Abstract][Full Text] [Related]
18. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.
Schroeder WT; Chao LY; Dao DD; Strong LC; Pathak S; Riccardi V; Lewis WH; Saunders GF
Am J Hum Genet; 1987 May; 40(5):413-20. PubMed ID: 2883892
[TBL] [Abstract][Full Text] [Related]
19. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
